Zobrazeno 1 - 10
of 38
pro vyhledávání: '"M.V. Bluthgen"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
G. Recondo, S. Akselrad, F. Jauk, P. Teves, J. Pandolfi, L. Basbus, C.A. Franco Cortes, H. Garcia Rivello, R. Sanchez Marull, Y. Powazniak, J. Calderazzo, M.V. Bluthgen, S.N. Sena, A. Perfetti, P.P. Levit, N. Castagneris, M.M. Rizzo, L. Lupinacci, J.N. Minatta
Publikováno v:
Annals of Oncology. 33:S968
Autor:
E. Seguí, T. Gorria, E. Auclin, J.M. Torres, D. Casadevall, J. Aguilar-Company, M. Rodríguez, N. Epaillard, J. Gavira, J.C. Tapia, M. Tagliamento, S. Pilotto, R. López-Castro, X. Mielgo, C. Urbano, J. Bautista Blaquier, M.V. Bluthgen, J.N. Minatta, A. Prat, A. Vlagea, L. Mezquita
Publikováno v:
Journal of Thoracic Oncology. 17:S112
Autor:
M.P. Spotti, N.J. Minatta, M.M. Rizzo, N. Castagneris, J.B. Blaquier, S.N. Sena, G. Recondo (h), M.V. Bluthgen
Publikováno v:
Journal of Thoracic Oncology. 17:S584
Autor:
Pierre-Emmanuel Falcoz, S. Lyubimova, Benjamin Besse, Jose Carlos Benitez, F. Thillays, Nicolas Girard, P.A. Thomas, Eric Dansin, Eric Pichon, Youssef Oulkhouir, Mallorie Kerjouan, Fabien Calcagno, Luc Thiberville, M.V. Bluthgen, V. Weestel, Jean-Michel Maury, P. Missy, M-E. Boucher, Laurence Bigay-Game, Thierry Jo Molina, Christelle Clément-Duchêne
Publikováno v:
Journal of Thoracic Oncology. 16:S895-S896
Autor:
N. Epaillard, Aleix Prat, Edouard Auclin, M. Garcia De Herreros, Cristina Cruz, Elia Seguí, C. Urbano, Nadia Saoudi, M.V. Bluthgen, X. Mielgo, L. Masfarré, O. Mirallas, R. López-Castro, D. Casadevall, J.N. Minatta, D. Pesántez, M. Tagliamento, Sara Pilotto, Laura Mezquita, M. Rodriguez
Publikováno v:
Annals of Oncology
Background: COVID-19 pandemic has drastically changed the management of patients with cancer;however, limited data exists regarding which pre-conditions affect the course of COVID-19 infection Here, we sought to assess the clinical features and outco
Autor:
J.N. Minatta, Oriol Mirallas, Cristino Cruz, F. M. Laia, C. Urbano Centella, X. Mielgo Rubio, M. Rodriguez Castells, R. López-Castro, Laura Mezquita, Estela Pineda, Aleix Prat, Edouard Auclin, M.V. Bluthgen, D. Casadevall Aguilar, N. Epaillard, L. Masfarré, M. Tagliamento, Sara Pilotto, N. Saoudi Gonzalez, G. D. H. Marta
Publikováno v:
Annals of Oncology
Background: Smoking is the leading cause of cancer worldwide Active smoking alters the inflammatory environment of the respiratory epithelium, increasing the production of potent pro-inflammatory cytokines that promote the recruitment of macrophages
Autor:
Frank Aboubakar, M. Sereno Moyano, M.V. Bluthgen, Laura Mezquita, Benjamin Besse, David J. Pinato, Caroline Caramella, N. Dempsey, Jose Carlos Ruffinelli, I. Sullivan, Sara Pilotto, C. Aguado de la Rosa, David Planchard, Lizza E.L. Hendriks, X. Mielgo Rubio, Ernest Nadal, P. Cruz Castellano, A. Amores, Bertrand Routy, R. Lopez Castro, G. Lopez, M. Castonguay, Edouard Auclin, Boris Duchemann, A. Rodriguez, F. Blanc-Durand, Santiago Ponce-Aix
Publikováno v:
Journal of Thoracic Oncology. 16:S205-S206
Autor:
Chloe Pannet, V. Faugeroux, Jordi Remon, Stefan Michiels, Françoise Farace, Guillaume Bescher, Emma Pailler, David Planchard, Caroline Caramella, Maud Ngo-Camus, Francesco Facchinetti, M.V. Bluthgen, Benjamin Besse, J-C. Soria, F. Billiot, Colin R Lindsay, D. Ou
Publikováno v:
Annals of Oncology. 28:1523-1531
Background We report the first study examining the clinical, numerical and biological properties of circulating tumor cells according to molecular subtypes of non-small-cell lung cancer. Patients and methods 125 patients with treatment-naive stage II
Autor:
Sarah Smalley, Caroline Caramella, A. Gazzah, Chloe Pannet, Ludovic Lacroix, Nitzan Rosenfeld, M.V. Bluthgen, Vincent Plagnol, Claudio Nicotra, Jordi Remon, Benjamin Besse, Andrew R. J. Lawson, J-C. Soria, Cécile Jovelet, David Planchard, Karen Howarth, Emma Green, Edouard Auclin, Davina Gale
Publikováno v:
Annals of Oncology. 28:784-790
Background Approximately 50% of epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC) patients treated with EGFR tyrosine kinase inhibitors (TKIs) will acquire resistance by theT790M mutation. Osimertinib is the standard o